🌊 Negócios em Emersão  ·  Vamos Emergir?  ·  Cadastre-se e ganhe 50 REC de bônus
Notícias

Acompanhe as Notícias da Recifes

Fique por dentro das últimas novidades sobre tecnologia, negócios e empreendedorismo.

202 notícias encontradas para "loss"
Modest sleep loss linked to weight gain in adults with high cardiometabolic risk
A pooled analysis of two randomized trials found that decreasing sleep by just 1.5 hours each night was associated with increases in body weight, waist circumference and sedentary time in adults with elevated cardiometabolic risk.
Foto: Miro Vrlik / Pexels
Training device expands access to high-performance diagnostic testing
The rise of automation and AI has raised fears about job loss, but smart tools can also train workers rather than replace them. Meanwhile, a chronic shortage of trained personnel limits the reach of health care in both developing and developed countries.
Foto: Abhishek  Navlakha / Pexels
Medicare GLP-1 Bridge program may lead to bone problems
The new Medicare GLP-1 Bridge program offers broader, more affordable access to weight loss drugs to address the growing obesity crisis. But there's a catch when it comes to bone health.
After weight loss, exercise improves cardiovascular health more than weight-loss medicatio
After weight loss, exercise improves cardiovascular health more than weight-loss medicatio
People with severe obesity who exercise regularly have healthier blood vessels and lower inflammation than those who rely on medication alone, a new study from the University of Copenhagen shows.
Most obesity drugs do not improve quality of life or heart health, analysis indicates
Most obesity drugs do not improve quality of life or heart health, analysis indicates
Despite substantial weight loss, most obesity drugs such as Wegovy and Mounjaro do not meaningfully improve quality of life, and few show cardiovascular benefits at one year, according to an analysis of the latest evidence published by The BMJ.
Foto: Nataliya Vaitkevich / Pexels
GLP-1 agonists may help people with diabetes and long COVID, study in mice suggests
GLP-1 agonists have become popular treatments for weight loss and type 2 diabetes, and newer studies suggest other health benefits as well. Findings from experiments on mice, published in the Journal of Virology, suggest that the drugs may offer benefits to another patient popula
Societies combine to issue recommendations on use of incretin drugs in obesity therapy
Obesity and dietitian societies have joined forces to issue a new consensus statement on recommendations surrounding the use of obesity drugs for weight loss treatment. The statement, which is published in The Lancet Diabetes & Endocrinology, is led by Dr. Laurence Dobbie of the
GLP-1 use hits record high as Medicare opens access to weight-loss drugs
The share of U.S. adults taking GLP-1 medications to lose weight has reached a record 11%. O recorte ajuda a contextualizar a pauta dentro de Fitness.
Foto: Mikhail Nilov / Pexels
Weight‑loss jabs may create a new kind of yo‑yo dieting
For many people living with obesity, newer weight-loss medicines such as Wegovy and Mounjaro have been transformative. These drugs are often grouped under the label GLP-1 medicines because they mimic hormones released after eating, helping people feel fuller and less hungry. Moun
Foto: Tara Winstead / Pexels
Genetic mapping identifies new hope for bone diseases
In a global breakthrough published in Nature Genetics, researchers have successfully mapped the cells and genes that regulate bone formation and loss at an unprecedented scale and discovered the critical role that blood vessel cells play in bone health.
Forget GLP-1s—GLP-3s show promise in phase 3 weight loss and diabetes trial
Forget GLP-1s—GLP-3s show promise in phase 3 weight loss and diabetes trial
Phase 3 clinical trial results (TRANSCEND-T2D-1) published in The Lancet report that retatrutide, an investigational once-weekly injection for diabetes management, can significantly improve blood sugar levels and lead to substantial weight loss in people with Type 2 diabetes. The
Foto: Google DeepMind / Pexels
Gene discovery may unlock infertility, early menopause clues
Most women are aware that fertility declines dramatically with age. This is mainly due to the gradual loss of eggs and follicles from the ovaries, leading to infertility, irregular cycles and ultimately menopause.